{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:15:07Z","timestamp":1792412107246,"version":"4.4.0"},"reference-count":300,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background and Objectives: Metabolic syndrome (MetS) is a condition marked by a complex array of physiological, biochemical, and metabolic abnormalities, including central obesity, insulin resistance, high blood pressure, and dyslipidemia (characterized by elevated triglycerides and reduced levels of high-density lipoproteins). The pathogenesis develops from the accumulation of lipid droplets in the hepatocyte (steatosis). This accumulation, in genetically predisposed subjects and with other external stimuli (intestinal dysbiosis, high caloric diet, physical inactivity, stress), activates the production of pro-inflammatory molecules, alter autophagy, and turn on the activity of hepatic stellate cells (HSCs), provoking the low grade chronic inflammation and the fibrosis. This syndrome is associated with a significantly increased risk of developing type 2 diabetes mellitus (T2D), cardiovascular diseases (CVD), vascular, renal, pneumologic, rheumatological, sexual, cutaneous syndromes and overall mortality, with the risk rising five- to seven-fold for T2DM, three-fold for CVD, and one and a half\u2013fold for all-cause mortality. The purpose of this narrative review is to examine metabolic syndrome as a \u201csystemic disease\u201d and its interaction with major internal medicine conditions such as CVD, diabetes, renal failure, and respiratory failure. It is essential for internal medicine practitioners to approach this widespread condition in a \u201cholistic\u201d rather than a fragmented manner, particularly in Western countries. Additionally, it is important to be aware of the non-invasive tools available for assessing this condition. Materials and Methods: We conducted an exhaustive search on PubMed up to July 2024, focusing on terms related to metabolic syndrome and other pathologies (heart, Lung (COPD, asthma, pulmonary hypertension, OSAS) and kidney failure, vascular, rheumatological (osteoarthritis, rheumatoid arthritis), endocrinological, sexual pathologies and neoplastic risks. The review was managed in accordance with the PRISMA statement. Finally, we selected 300 studies (233 papers for the first search strategy and 67 for the second one). Our review included studies that provided insights into metabolic syndrome and non-invasive techniques for evaluating liver fibrosis and steatosis. Studies that were not conducted on humans, were published in languages other than English, or did not assess changes related to heart failure were excluded. Results: The findings revealed a clear correlation between metabolic syndrome and all the pathologies above described, indicating that non-invasive assessments of hepatic fibrosis and steatosis could potentially serve as markers for the severity and progression of the diseases. Conclusions: Metabolic syndrome is a multisystem disorder that impacts organs beyond the liver and disrupts the functioning of various organs. Notably, it is linked to a higher incidence of cardiovascular diseases, independent of traditional cardiovascular risk factors. Non-invasive assessments of hepatic fibrosis and fibrosis allow clinicians to evaluate cardiovascular risk. Additionally, the ability to assess liver steatosis may open new diagnostic, therapeutic, and prognostic avenues for managing metabolic syndrome and its complications, particularly cardiovascular disease, which is the leading cause of death in these patients.<\/jats:p>","DOI":"10.3390\/jcm13195880","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T06:27:31Z","timestamp":1727850451000},"page":"5880","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5347-0183","authenticated-orcid":false,"given":"Francesco","family":"Giangregorio","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Mosconi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Debellis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Provini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Garolfi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Oraka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kaloudi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunel","family":"Mustafazade","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Codogno Hospital, Via Marconi 1, 26900 Codogno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Mar\u00edn-Baselga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Universitario La Paz, Paseo Castellana 241, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yale","family":"Tung-Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Universitario La Paz, Paseo Castellana 241, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trsl.2017.01.001","article-title":"Cardiovascular consequences of metabolic syndrome","volume":"183","author":"Tune","year":"2017","journal-title":"Transl. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000226220","article-title":"Vascular disease in the metabolic syndrome: Do we need to target the microcirculation to treat large vessel disease?","volume":"46","author":"Krentz","year":"2009","journal-title":"J. Vasc. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.chest.2015.12.034","article-title":"Metabolic Syndrome and the Lung","volume":"149","author":"Baffi","year":"2016","journal-title":"Chest"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e13649","DOI":"10.1111\/obr.13649","article-title":"Association of metabolic syndrome and chronic kidney disease","volume":"25","author":"Scurt","year":"2024","journal-title":"Obes. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.2337\/diacare.27.12.3009","article-title":"Dyslipidemia and the metabolic syndrome","volume":"27","author":"Bloomgarden","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Raya-Cano, E., Vaquero-Abellan, M., Molina-Luque, R., De Pedro-Jimenez, D., Molina-Recio, G., and Romero-Saldana, M. (2022). Association between metabolic syndrome and uric acid: A systematic review and meta-analysis. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-22025-2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: From obesity to metabolic syndrome and diabetes","volume":"12","author":"Valerio","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kicinska, A.M., Maksym, R.B., Zabielska-Kaczorowska, M.A., Stachowska, A., and Babinska, A. (2023). Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061567"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Nunes, D.C., Ribeiro, J.C., Alves, M.G., Oliveira, P.F., and Bernardino, R.L. (2023). Male Sex Hormones, Metabolic Syndrome, and Aquaporins: A Triad of Players in Male (in)Fertility. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24031960"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e38647","DOI":"10.1097\/MD.0000000000038647","article-title":"Polycystic ovary syndrome and its multidimensional impacts on women\u2019s mental health: A narrative review","volume":"103","author":"Almhmoud","year":"2024","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13098-018-0311-z","article-title":"Metabolic syndrome and the skin: A more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients","volume":"10","author":"Stefanadi","year":"2018","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000443743","article-title":"Association between Metabolic Syndrome and Cancer","volume":"68","author":"Uzunlulu","year":"2016","journal-title":"Ann. Nutr. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.mcna.2022.12.003","article-title":"Nonalcoholic Fatty Liver Disease: A Unique Entity or Part of the Metabolic Syndrome or Both","volume":"107","author":"Yip","year":"2023","journal-title":"Med. Clin. N. Am."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014A new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1463-1326.2006.00594.x","article-title":"Cardiovascular metabolic syndrome\u2014An interplay of, obesity, inflammation, diabetes and coronary heart disease","volume":"9","author":"Rana","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Alemany, M. (2024). The Metabolic Syndrome, a Human Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042251"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0016-5085(85)90761-9","article-title":"Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?","volume":"89","author":"Sanford","year":"1985","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","article-title":"Ultrasound scanning in the detection of hepatic fibrosis and steatosis","volume":"292","author":"Saverymuttu","year":"1986","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF01536033","article-title":"Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques","volume":"33","author":"Celle","year":"1988","journal-title":"Dig. Dis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiology.162.1.3538154","article-title":"Quantitative estimation of liver attenuation and echogenicity: Normal state versus diffuse liver disease","volume":"162","author":"Garra","year":"1987","journal-title":"Radiology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiology.160.1.3520657","article-title":"Quantitative US attenuation in normal liver and in patients with diffuse liver disease: Importance of fat","volume":"160","author":"Taylor","year":"1986","journal-title":"Radiology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","article-title":"The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis","volume":"38","author":"Palmentieri","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1381\/096089204323093408","article-title":"The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients","volume":"14","author":"Mottin","year":"2004","journal-title":"Obes. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11695-011-0509-8","article-title":"Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients","volume":"22","author":"Wu","year":"2012","journal-title":"Obes. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ali, A.H., Al Juboori, A., Petroski, G.F., Diaz-Arias, A.A., Syed-Abdul, M.M., Wheeler, A.A., Ganga, R.R., Pitt, J.B., Spencer, N.M., and Hammoud, G.M. (2022). The Utility and Diagnostic Accuracy of Transient Elastography in Adults with Morbid Obesity: A Prospective Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051201"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhu, L., Spence, C., Yang, J.W., and Ma, G.X. (2020). The IDF Definition Is Better Suited for Screening Metabolic Syndrome and Estimating Risks of Diabetes in Asian American Adults: Evidence from NHANES 2011\u20132016. J. Clin. Med., 9.","DOI":"10.3390\/jcm9123871"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S1262-3636(08)74598-1","article-title":"Definition and natural history of metabolic steatosis: Histology and cellular aspects","volume":"34","author":"Paradis","year":"2008","journal-title":"Diabetes Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1262-3636(08)74597-X","article-title":"Definition and natural history of metabolic steatosis: Clinical aspects of NAFLD, NASH and cirrhosis","volume":"34","author":"Serfaty","year":"2008","journal-title":"Diabetes Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"G194","DOI":"10.1152\/ajpgi.00413.2005","article-title":"Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis","volume":"290","author":"Bradbury","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Masenga, S.K., Kabwe, L.S., Chakulya, M., and Kirabo, A. (2023). Mechanisms of Oxidative Stress in Metabolic Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24097898"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Prasun, P. (2020). Mitochondrial dysfunction in metabolic syndrome. Biochim. Biophys. Acta Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165838"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.2174\/0929867324666170518101334","article-title":"Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis","volume":"26","author":"Vergani","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_41","first-page":"99","article-title":"Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease","volume":"40","author":"Guarner","year":"2015","journal-title":"Interdiscip. Top. Gerontol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41574-021-00551-9","article-title":"Autophagy in metabolic disease and ageing","volume":"17","author":"Kitada","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s11739-024-03700-w","article-title":"Autophagy alterations in obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease: The evidence from human studies","volume":"19","author":"Jakubek","year":"2024","journal-title":"Intern. Emerg. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shen, Q., Yang, M., Wang, S., Chen, X., Chen, S., Zhang, R., Xiong, Z., and Leng, Y. (2024). The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1374644"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Akkiz, H., Gieseler, R.K., and Canbay, A. (2024). Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147873"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"ref_47","first-page":"283","article-title":"Nonalcoholic fatty liver disease","volume":"8","author":"Schaffner","year":"1986","journal-title":"Prog. Liver Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0261-5614(99)80015-6","article-title":"Non-alcoholic fatty liver: Another feature of the metabolic syndrome?","volume":"18","author":"Camilo","year":"1999","journal-title":"Clin. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4254\/wjh.v7.i10.1325","article-title":"Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis","volume":"7","author":"Polimeni","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Baratta, F., Pastori, D., Bartimoccia, S., Cammisotto, V., Cocomello, N., Colantoni, A., Nocella, C., Carnevale, R., Ferro, D., and Angelico, F. (2020). Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients, 12.","DOI":"10.3390\/nu12061732"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ferro, D., Baratta, F., Pastori, D., Cocomello, N., Colantoni, A., Angelico, F., and Del Ben, M. (2020). New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Nutrients, 12.","DOI":"10.3390\/nu12092762"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejim.2014.05.012","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants","volume":"25","author":"Polimeni","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Di Costanzo, A., Belardinilli, F., Bailetti, D., Sponziello, M., D\u2019Erasmo, L., Polimeni, L., Baratta, F., Pastori, D., Ceci, F., and Montali, A. (2018). Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-21939-0"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Carpino, G., Pastori, D., Baratta, F., Overi, D., Labbadia, G., Polimeni, L., Di Costanzo, A., Pannitteri, G., Carnevale, R., and Del Ben, M. (2017). PNPLA3 variant and portal\/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: A possible role for oxidative stress. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-15943-z"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2016.12.018","article-title":"Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage","volume":"257","author":"Polimeni","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.1999.tb07783.x","article-title":"Etiology of the metabolic syndrome: Potential role of insulin resistance, leptin resistance, and other players","volume":"892","author":"Zimmet","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/msj.20212","article-title":"Insulin resistance in obesity as the underlying cause for the metabolic syndrome","volume":"77","author":"Gallagher","year":"2010","journal-title":"Mt. Sinai J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/ATVBAHA.111.241869","article-title":"Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets","volume":"32","author":"Romeo","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1479164119827611","article-title":"Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift","volume":"16","author":"Nolan","year":"2019","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.ijo.0801837","article-title":"Factor analysis of the metabolic syndrome: Obesity vs insulin resistance as the central abnormality","volume":"25","author":"Anderson","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1185\/030079903125003008","article-title":"Obesity as the core of the metabolic syndrome and the management of coronary heart disease","volume":"20","author":"Shirai","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despres","year":"2006","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2362.2010.02357.x","article-title":"Lipid assessment, metabolic syndrome and coronary heart disease risk","volume":"40","author":"Arsenault","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2007.08.009","article-title":"Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity","volume":"197","author":"Vindis","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/diabetes.52.10.2453","article-title":"Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog","volume":"52","author":"Kim","year":"2003","journal-title":"Diabetes"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1440-1746.2007.04824.x","article-title":"Non-alcoholic fatty liver disease: Further expression of the metabolic syndrome","volume":"22","author":"Tarantino","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/clc.20496","article-title":"Metabolic syndrome increases mortality in heart failure","volume":"32","author":"Tamariz","year":"2009","journal-title":"Clin. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.mcna.2007.06.003","article-title":"Cardiovascular morbidity and mortality of the metabolic syndrome","volume":"91","author":"Obunai","year":"2007","journal-title":"Med. Clin. N. Am."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2005.06.007","article-title":"Cardiovascular risk factors are really linked in the metabolic syndrome: This phenomenon suggests clustering rather than coincidence","volume":"109","author":"Aizawa","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1743-7075-8-74","article-title":"Utilization of dietary glucose in the metabolic syndrome","volume":"8","author":"Alemany","year":"2011","journal-title":"Nutr. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cen.12664","article-title":"Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: A systematic review and meta-analysis of randomized controlled clinical trials","volume":"83","author":"Grossmann","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.4239\/wjd.v12.i10.1622","article-title":"Estrogens and the regulation of glucose metabolism","volume":"12","author":"Alemany","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.nutr.012809.104723","article-title":"Central nervous system nutrient signaling: The regulation of energy balance and the future of dietary therapies","volume":"30","author":"Stefater","year":"2010","journal-title":"Annu. Rev. Nutr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1467-789X.2005.00193.x","article-title":"Fuel sensing and the central nervous system (CNS): Implications for the regulation of energy balance and the treatment for obesity","volume":"6","author":"Seeley","year":"2005","journal-title":"Obes. Rev."},{"key":"ref_83","first-page":"155","article-title":"Metabolic Syndrome: A Multifaceted Disease of Affluence","volume":"2","author":"Alemany","year":"2012","journal-title":"J. Endocrinol. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1463-1326.2006.00590.x","article-title":"Ectopic fat accumulation and metabolic syndrome","volume":"9","author":"Rasouli","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"T25","DOI":"10.1530\/JOE-13-0398","article-title":"Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance","volume":"220","author":"Schneeberger","year":"2014","journal-title":"J. Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.diabet.2010.11.001","article-title":"Brain lipid sensing and nervous control of energy balance","volume":"37","author":"Migrenne","year":"2011","journal-title":"Diabetes Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2337\/db06-0376","article-title":"Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: The cerebral basis for impaired control of food intake in metabolic syndrome?","volume":"55","author":"Anthony","year":"2006","journal-title":"Diabetes"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"135984","DOI":"10.1155\/2013\/135984","article-title":"Inflammation is a key pathophysiological feature of metabolic syndrome","volume":"2013","author":"Montecucco","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_89","first-page":"121","article-title":"Influence of inflammation and adipocyte biochemical markers on the components of metabolic syndrome","volume":"20","author":"Vesa","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Ion, R.M., Sibianu, M., Hutanu, A., Beresescu, F.G., Sala, D.T., Flavius, M., Rosca, A., Constantin, C., Scurtu, A., and Moriczi, R. (2023). A Comprehensive Summary of the Current Understanding of the Relationship between Severe Obesity, Metabolic Syndrome, and Inflammatory Status. J. Clin. Med., 12.","DOI":"10.3390\/jcm12113818"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.semnephrol.2011.08.002","article-title":"Uric acid: A danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: Evolutionary considerations","volume":"31","author":"Johnson","year":"2011","journal-title":"Semin. Nephrol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Yoo, J.J., Cho, E.J., Chung, G.E., Chang, Y., Cho, Y., Park, S.H., Jeong, S.M., Kim, B.Y., Shin, D.W., and Kim, Y.J. (2022). Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults. J. Clin. Med., 11.","DOI":"10.3390\/jcm11040935"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Remesar, X., and Alemany, M. (2020). Dietary Energy Partition: The Central Role of Glucose. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207729"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Caturano, A., Acierno, C., Nevola, R., Pafundi, P.C., Galiero, R., Rinaldi, L., Salvatore, T., Adinolfi, L.E., and Sasso, F.C. (2021). Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact. Processes, 9.","DOI":"10.3390\/pr9010135"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2337\/db17-0046","article-title":"Opposite Regulation of Insulin Sensitivity by Dietary Lipid Versus Carbohydrate Excess","volume":"66","author":"Lundsgaard","year":"2017","journal-title":"Diabetes"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"London, A., Lundsgaard, A.M., Kiens, B., and Bojsen-Moller, K.N. (2021). The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis-Dysregulation by the Liver. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030390"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2004-1024","article-title":"Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease","volume":"90","author":"Angelico","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_99","first-page":"41","article-title":"Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from That of Diabetes or Obesity?","volume":"8","author":"Sowers","year":"2017","journal-title":"Cardiorenal Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1152\/physiolgenomics.00016.2010","article-title":"Men supplemented with 17beta-estradiol have increased beta-oxidation capacity in skeletal muscle","volume":"42","author":"Maher","year":"2010","journal-title":"Physiol. Genom."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11886-014-0467-6","article-title":"Endogenous sex hormones, metabolic syndrome, and diabetes in men and women","volume":"16","author":"Kim","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI114345","article-title":"Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium","volume":"84","author":"Hauner","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1189\/jlb.0208104","article-title":"The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease","volume":"84","author":"Tait","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00281-020-00827-8","article-title":"Control of immunity by glucocorticoids in health and disease","volume":"42","author":"Shimba","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"Taves","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08923973.2020.1728765","article-title":"New insights into the novel anti-inflammatory mode of action of glucocorticoids","volume":"42","author":"Ingawale","year":"2020","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/ATVBAHA.114.304454","article-title":"Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis","volume":"35","author":"Borst","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00925945","article-title":"Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA)","volume":"131","author":"Kalimi","year":"1994","journal-title":"Mol. Cell. Biochem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"11795514221145841","DOI":"10.1177\/11795514221145841","article-title":"Stress Induced Cortisol Release Depresses The Secretion of Testosterone in Patients With Type 2 Diabetes Mellitus","volume":"16","author":"Khan","year":"2023","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_111","first-page":"197","article-title":"Glucocorticoid-induced depression\u2014The role of the dopaminergic system and microRNAs","volume":"30","author":"Skorzewska","year":"2021","journal-title":"Postep. Psychiatr. Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Purslow, P.P. (2020). The Structure and Role of Intramuscular Connective Tissue in Muscle Function. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00495"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1172\/JCI81507","article-title":"Abdominal obesity: A marker of ectopic fat accumulation","volume":"125","author":"Smith","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Fede, C., Fan, C., Pirri, C., Petrelli, L., Biz, C., Porzionato, A., Macchi, V., De Caro, R., and Stecco, C. (2022). The Effects of Aging on the Intramuscular Connective Tissue. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911061"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2019.03.030","article-title":"Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases","volume":"165","author":"Francisco","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"343746","DOI":"10.1155\/2014\/343746","article-title":"Adipokines, metabolic syndrome and rheumatic diseases","volume":"2014","author":"Abella","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Chen, W.L., Wang, C.C., Wu, L.W., Kao, T.W., Chan, J.Y., Chen, Y.J., Yang, Y.H., Chang, Y.W., and Peng, T.C. (2014). Relationship between lung function and metabolic syndrome. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108989"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Sitar-Taut, A.V., Cozma, A., Fodor, A., Coste, S.C., Orasan, O.H., Negrean, V., Pop, D., and Sitar-Taut, D.A. (2021). New Insights on the Relationship between Leptin, Ghrelin, and Leptin\/Ghrelin Ratio Enforced by Body Mass Index in Obesity and Diabetes. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111657"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.27134","article-title":"Is the adiponectin-AMPK-mitochondrial axis involved in progression of nonalcoholic fatty liver disease?","volume":"60","author":"Dasarathy","year":"2014","journal-title":"Hepatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/met.2018.0012","article-title":"Vaspin and Omentin-1 in Obese Children with Metabolic Syndrome: Two New Kids on the Block?","volume":"16","author":"Kumar","year":"2018","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/S0007114522003580","article-title":"The effect of dietary carbohydrate restriction and aerobic exercise on retinol binding protein 4 (RBP4) and fatty acid binding protein 5 (FABP5) in middle-aged men with metabolic syndrome","volume":"130","author":"Ghorbanian","year":"2023","journal-title":"Br. J. Nutr."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/pedi.13101","article-title":"Adropin and apelin-12 efficiently predict metabolic syndrome in obese children","volume":"21","author":"Yin","year":"2020","journal-title":"Pediatr. Diabetes"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2174\/1381612823666170124114524","article-title":"Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension","volume":"23","author":"Korolczuk","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_124","first-page":"129","article-title":"Assessment of progranulin and FAM19A5 protein blood levels in patients with metabolic syndrome","volume":"73","author":"Wesolek","year":"2022","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Samsamshariat, S.Z.A., Sakhaei, F., Salehizadeh, L., Keshvari, M., and Asgary, S. (2019). Relationship between Resistin, Endothelin-1, and Flow-Mediated Dilation in Patient with and without Metabolic Syndrome. Adv. Biomed. Res., 8.","DOI":"10.4103\/abr.abr_126_18"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Pan, X., Wen, S.W., Bestman, P.L., Kaminga, A.C., Acheampong, K., and Liu, A. (2020). Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0229776"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.dsx.2019.06.005","article-title":"An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome","volume":"13","author":"Kumari","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Kim, J.E., Kim, J.S., Jo, M.J., Cho, E., Ahn, S.Y., Kwon, Y.J., and Ko, G.J. (2022). The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome. Molecules, 27.","DOI":"10.3390\/molecules27020334"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/all.13788","article-title":"Innate immunity in allergy","volume":"74","author":"Maeda","year":"2019","journal-title":"Allergy"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.medntd.2020.100052","article-title":"Metabolic syndrome and osteoarthritis: Possible mechanisms and management strategies","volume":"9","author":"Tan","year":"2021","journal-title":"Med. Nov. Technol. Devices"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archderm.144.12.1571","article-title":"Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome","volume":"144","author":"Chen","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/met.2023.0006","article-title":"The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome","volume":"21","author":"Nichols","year":"2023","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/dom.14916","article-title":"Chronic kidney disease begets heart failure and vice versa: Temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes","volume":"25","author":"Wu","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5527\/wjn.v3.i4.210","article-title":"Metabolic syndrome and chronic kidney disease: Current status and future directions","volume":"3","author":"Prasad","year":"2014","journal-title":"World J. Nephrol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Lin, L., Tan, W., Pan, X., Tian, E., Wu, Z., and Yang, J. (2022). Metabolic Syndrome-Related Kidney Injury: A Review and Update. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.904001"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4239\/wjd.v8.i7.317","article-title":"Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia","volume":"8","author":"Mbata","year":"2017","journal-title":"World J. Diabetes"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/JOM.0000000000002569","article-title":"Association Between the Metabolic Syndrome and Retinal Microvascular Diameters Among Police Officers","volume":"64","author":"Gu","year":"2022","journal-title":"J. Occup. Environ. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-021-09708-3","article-title":"Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review","volume":"23","author":"Camastra","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1113\/JP275856","article-title":"Pulmonary vascular dysfunction in metabolic syndrome","volume":"597","author":"Willson","year":"2019","journal-title":"J. Physiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e2140568","DOI":"10.1001\/jamanetworkopen.2021.40568","article-title":"Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients with COVID-19","volume":"4","author":"Denson","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2337\/dc11-0682","article-title":"Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: The Strong Heart Study","volume":"34","author":"Yeh","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1089\/met.2022.0045","article-title":"Pulmonary Function in Metabolic Syndrome: A Meta-Analysis","volume":"20","author":"Fang","year":"2022","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e047849","DOI":"10.1136\/bmjopen-2020-047849","article-title":"Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: A retrospective cohort study","volume":"11","author":"Lim","year":"2021","journal-title":"BMJ Open"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1152\/japplphysiol.00781.2009","article-title":"Obesity and lung inflammation","volume":"108","author":"Mancuso","year":"2010","journal-title":"J. Appl. Physiol. (1985)"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/1687-8426.198983","article-title":"The relationship between metabolic syndrome and chronic obstructive pulmonary disease","volume":"11","author":"Ghatas","year":"2017","journal-title":"Egypt. J. Bronchol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"120","DOI":"10.34172\/jcvtr.2020.20","article-title":"Asthma and metabolic syndrome: A comprehensive systematic review and meta-analysis of observational studies","volume":"12","author":"Karamzad","year":"2020","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/obesities3010005","article-title":"Why Are Obese People Predisposed to Severe Disease in Viral Respiratory Infections?","volume":"3","author":"Aziz","year":"2023","journal-title":"Obesities"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Geerling, E., Hameed, M., Weger-Lucarelli, J., and Pinto, A.K. (2022). Metabolic syndrome and aberrant immune responses to viral infection and vaccination: Insights from small animal models. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1015563"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-021-01374-8","article-title":"The association of hepatic steatosis and fibrosis with heart failure and mortality","volume":"20","author":"Park","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12933-022-01725-z","article-title":"The associations between changes in hepatic steatosis and heart failure and mortality: A nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/hrt.2006.089011","article-title":"Metabolic syndrome and risk for heart failure in middle-aged men","volume":"92","author":"Ingelsson","year":"2006","journal-title":"Heart"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2362.1996.2880577.x","article-title":"The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats","volume":"26","author":"Holmang","year":"1996","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI107996","article-title":"The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man","volume":"55","author":"DeFronzo","year":"1975","journal-title":"J. Clin. Investig."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI115260","article-title":"Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans","volume":"87","author":"Anderson","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1172\/JCI117593","article-title":"Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension","volume":"94","author":"Gaboury","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/0026-0495(91)90075-8","article-title":"Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure","volume":"40","author":"Paolisso","year":"1991","journal-title":"Metabolism"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","article-title":"Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure","volume":"49","author":"Levine","year":"1982","journal-title":"Am. J. Cardiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jacc.2014.04.083","article-title":"Metabolic impairment in heart failure: The myocardial and systemic perspective","volume":"64","author":"Doehner","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cardiores.2003.11.027","article-title":"The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy","volume":"61","author":"Nikolaidis","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jacc.2006.06.078","article-title":"Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease","volume":"48","author":"Dutka","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","article-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","volume":"21","author":"Suskin","year":"2000","journal-title":"Eur. Heart J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.294.3.334","article-title":"Insulin resistance and risk of congestive heart failure","volume":"294","author":"Ingelsson","year":"2005","journal-title":"JAMA"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jech.2006.048173","article-title":"Association of metabolic syndrome and insulin resistance with congestive heart failure: Findings from the Third National Health and Nutrition Examination Survey","volume":"61","author":"Li","year":"2007","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1253\/circj.CJ-10-0677","article-title":"Prevalence and clinical implication of metabolic syndrome in chronic heart failure","volume":"74","author":"Miura","year":"2010","journal-title":"Circ. J."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2014.10.094","article-title":"Prognostic impact of metabolic syndrome in patients with chronic heart failure: Data from GISSI-HF trial","volume":"178","author":"Savarese","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.hfc.2019.02.004","article-title":"Metabolic Syndrome in Heart Failure: Friend or Foe?","volume":"15","author":"Arcopinto","year":"2019","journal-title":"Heart Fail. Clin."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0735-1097(97)00185-X","article-title":"Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure","volume":"30","author":"Swan","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jacc.2005.06.015","article-title":"More risk factors affecting heart failure outcomes! Time for hope or despair?","volume":"46","author":"Butler","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCOUTCOMES.110.957225","article-title":"Lifetime costs of medical care after heart failure diagnosis","volume":"4","author":"Dunlay","year":"2011","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail."},{"key":"ref_173","first-page":"1446","article-title":"Health care costs for patients with heart failure escalate nearly 3-fold in final months of life","volume":"22","author":"Obi","year":"2016","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e3502","DOI":"10.1002\/dmrr.3502","article-title":"Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors","volume":"38","author":"Barbalho","year":"2022","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1007\/BF03347077","article-title":"Hypertension is the metabolic syndrome component most strongly associated with microvascular complications and coronary artery calcification in Type 1 diabetes","volume":"34","author":"Rodrigues","year":"2011","journal-title":"J. Endocrinol. Investig."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Soleimani, M., Barone, S., Luo, H., and Zahedi, K. (2023). Pathogenesis of Hypertension in Metabolic Syndrome: The Role of Fructose and Salt. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054294"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.arcmed.2015.05.007","article-title":"Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis","volume":"46","year":"2015","journal-title":"Arch. Med. Res."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Moghadam-Ahmadi, A., Soltani, N., Ayoobi, F., Jamali, Z., Sadeghi, T., Jalali, N., Vakilian, A., Lotfi, M.A., and Khalili, P. (2023). Association between metabolic syndrome and stroke: A population based cohort study. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-023-01383-6"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12933-021-01215-8","article-title":"Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: A nationwide population-based study","volume":"20","author":"Ahn","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.18087\/cardio.2023.12.n2360","article-title":"Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure","volume":"63","author":"Misan","year":"2023","journal-title":"Kardiologiia"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12933-020-01044-1","article-title":"Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: A (1)H-magnetic resonance spectroscopy study","volume":"19","author":"Gao","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1573403X16666200214104122","article-title":"Association Between Sarcopenic Obesity and Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis","volume":"16","author":"Khadra","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/HJH.0b013e328337a9e3","article-title":"Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events","volume":"28","author":"Mancia","year":"2010","journal-title":"J. Hypertens."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2265.2007.02798.x","article-title":"Metabolic syndrome increases all-cause and vascular mortality: The Hong Kong Cardiovascular Risk Factor Study","volume":"66","author":"Thomas","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/CDM.1000158","article-title":"Pathological basis of cardiac arrhythmias: Vicious cycle of immune-metabolic dysregulation","volume":"3","author":"Wang","year":"2017","journal-title":"Cardiovasc. Disord. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-4-28","article-title":"Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?","volume":"4","author":"Kraja","year":"2007","journal-title":"Nutr. Metab."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCHEARTFAILURE.108.821892","article-title":"Heart failure as a multiple hormonal deficiency syndrome","volume":"2","author":"Sacca","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2003.11.039","article-title":"Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure","volume":"43","author":"Block","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jacc.2009.07.029","article-title":"Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure","volume":"55","author":"Horwich","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Writing Committee Members, Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Colvin, M.M., Drazner, M.H., Filippatos, G., and Fonarow, G.C. (2016). 2016 ACC\/AHA\/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation, 134, e282\u2013e293.","DOI":"10.1161\/CIR.0000000000000435"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1054\/jcaf.2003.4","article-title":"Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity","volume":"9","author":"Davos","year":"2003","journal-title":"J. Card. Fail."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ahj.2005.03.009","article-title":"The association between blood pressure and mortality in patients with heart failure","volume":"151","author":"Lee","year":"2006","journal-title":"Am. Heart J."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/hrt.2007.134973","article-title":"Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure","volume":"95","author":"Raphael","year":"2009","journal-title":"Heart"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.679","article-title":"In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: Results from the ESC-HFA Heart Failure Long-Term Registry","volume":"19","author":"Targher","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJM199006143222403","article-title":"Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease","volume":"322","author":"Pekkanen","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2009.04.049","article-title":"Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes","volume":"54","author":"Aguilar","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Alexander, K.S., Zakai, N.A., Lidofsky, S.D., Callas, P.W., Judd, S.E., Tracy, R.P., and Cushman, M. (2018). Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194153"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s10620-019-05986-9","article-title":"Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany","volume":"65","author":"Labenz","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12933-020-01064-x","article-title":"Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: A Korean cohort study","volume":"19","author":"Lee","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/EDE.0b013e3181feb50a","article-title":"Nonalcoholic fatty liver disease and acute ischemic stroke","volume":"22","author":"Ying","year":"2011","journal-title":"Epidemiology"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.18632\/oncotarget.22755","article-title":"Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: A meta-analysis","volume":"9","author":"Hu","year":"2018","journal-title":"Oncotarget"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","article-title":"Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review","volume":"49","author":"Sookoian","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/01.ATV.0000189299.61568.79","article-title":"Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease","volume":"25","author":"Targher","year":"2005","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/imj.13549","article-title":"Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes","volume":"47","author":"Zou","year":"2017","journal-title":"Intern. Med. J."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Arai, T., Atsukawa, M., Tsubota, A., Kawano, T., Koeda, M., Yoshida, Y., Tanabe, T., Okubo, T., Hayama, K., and Iwashita, A. (2019). Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224184"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Arai, T., Atsukawa, M., Tsubota, A., Kato, K., Abe, H., Ono, H., Kawano, T., Yoshida, Y., Tanabe, T., and Okubo, T. (2021). Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-95581-8"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2147\/DMSO.S205568","article-title":"The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: A retrospective case-control study","volume":"12","author":"Mahamid","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.trsl.2016.12.004","article-title":"The metabolic syndrome and chronic kidney disease","volume":"183","author":"Zhang","year":"2017","journal-title":"Transl. Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.gastrohep.2022.11.001","article-title":"Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes","volume":"46","author":"Pons","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1183\/09031936.00124912","article-title":"Airway and systemic inflammation in obese children with asthma","volume":"42","author":"Jensen","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"393192","DOI":"10.1155\/2013\/393192","article-title":"Adipose tissue dysfunction in nascent metabolic syndrome","volume":"2013","author":"Bremer","year":"2013","journal-title":"J. Obes."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1467-789X.2012.01055.x","article-title":"Gender difference of childhood overweight and obesity in predicting the risk of incident asthma: A systematic review and meta-analysis","volume":"14","author":"Chen","year":"2013","journal-title":"Obes. Rev."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1872214807666140107151023","article-title":"Metabolic syndrome and asthma","volume":"8","author":"Garmendia","year":"2014","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2147\/COPD.S228497","article-title":"Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs","volume":"14","author":"Choi","year":"2019","journal-title":"Int. J. Chron. Obs. Pulmon. Dis."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Liu, S., Zhang, H., and Lan, Z. (2024). Associations of obesity with chronic inflammatory airway diseases and mortality in adults: A population-based investigation. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-18782-6"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharmthera.2019.02.013","article-title":"Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): Clinical significance and therapeutic strategies","volume":"198","author":"Chan","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Piazzolla, G., Castrovilli, A., Liotino, V., Vulpi, M.R., Fanelli, M., Mazzocca, A., Candigliota, M., Berardi, E., Resta, O., and Sabba, C. (2017). Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186708"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jsmc.2024.02.009","article-title":"Obstructive Sleep Apnea, Obesity Hypoventilation Syndrome, and Pulmonary Hypertension: A State-of-the-Art Review","volume":"19","author":"Bjork","year":"2024","journal-title":"Sleep Med. Clin."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Garbarino, S., and Magnavita, N. (2014). Obstructive Sleep Apnea Syndrome (OSAS), metabolic syndrome and mental health in small enterprise workers. feasibility of an Action for Health. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097188"},{"key":"ref_220","first-page":"417","article-title":"Prevalence of metabolic syndrome diagnosis in patients with obstructive sleep apnoea syndrome according to adopted definition","volume":"81","author":"Kumor","year":"2013","journal-title":"Pneumonol. Alergol. Pol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4330\/wjc.v6.i8.692","article-title":"Pulmonary hypertension and metabolic syndrome: Possible connection, PPARgamma and Caveolin-1","volume":"6","author":"Mathew","year":"2014","journal-title":"World J. Cardiol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/bph.14968","article-title":"Metabolic syndrome, neurohumoral modulation, and pulmonary arterial hypertension","volume":"177","author":"Maron","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/crj.12406","article-title":"Prevalence of metabolic syndrome in patients with pulmonary hypertension","volume":"11","author":"Ussavarungsi","year":"2017","journal-title":"Clin. Respir. J."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","article-title":"Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use","volume":"23","author":"Kraus","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrrheum.2012.135","article-title":"Metabolic syndrome meets osteoarthritis","volume":"8","author":"Zhuo","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clindermatol.2017.09.008","article-title":"Acanthosis nigricans and the metabolic syndrome","volume":"36","author":"Karadag","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Matwiejuk, M., Mysliwiec, H., Chabowski, A., and Flisiak, I. (2023). An Overview of Growth Factors as the Potential Link between Psoriasis and Metabolic Syndrome. J. Clin. Med., 13.","DOI":"10.3390\/jcm13010109"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/oby.23444","article-title":"Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome","volume":"30","author":"Karra","year":"2022","journal-title":"Obesity"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/apt.15738","article-title":"Review article: The emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis","volume":"51","author":"Carlsson","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","article-title":"Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease","volume":"57","author":"Harrison","year":"2008","journal-title":"Gut"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/j.gastro.2017.06.005","article-title":"Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis","volume":"153","author":"Middleton","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ultrasmedbio.2024.03.013","article-title":"WFUMB Guideline\/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography","volume":"50","author":"Ferraioli","year":"2024","journal-title":"Ultrasound Med. Biol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5604\/01.3001.0009.8589","article-title":"Transient Elastography vs. Aspartate Aminotransferase to Platelet Ratio Index in Hepatitis C: A Meta-Analysis","volume":"16","author":"Mattos","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2019.07.033","article-title":"Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores","volume":"157","author":"Ioannou","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7150\/jca.16523","article-title":"Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir","volume":"8","author":"Nishikawa","year":"2017","journal-title":"J. Cancer"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ajg.2017.254","article-title":"Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma","volume":"112","author":"Tseng","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/apt.14619","article-title":"Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection","volume":"47","author":"Tseng","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","article-title":"Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study","volume":"46","author":"Sun","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Sumida, Y., Yoneda, M., Tokushige, K., Kawanaka, M., Fujii, H., Yoneda, M., Imajo, K., Takahashi, H., Eguchi, Y., and Ono, M. (2021). FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic. Life, 11.","DOI":"10.3390\/life11020143"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000480142","article-title":"Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients","volume":"35","author":"Kobayashi","year":"2017","journal-title":"Dig. Dis."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s10620-018-5123-3","article-title":"Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration","volume":"63","author":"Patel","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/MEG.0000000000001519","article-title":"Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease","volume":"32","author":"Correa","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Sumida, Y., Yoneda, M., Hyogo, H., Itoh, Y., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., Aoki, N., and Kanemasa, K. (2012). Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol., 12.","DOI":"10.1186\/1471-230X-12-2"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hep4.1105","article-title":"Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease","volume":"1","author":"Tada","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.29113","article-title":"Liver fibrosis scores predict liver disease mortality in the United States population","volume":"66","author":"Ruhl","year":"2017","journal-title":"Hepatology"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/liv.13739","article-title":"Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease","volume":"38","author":"Bertot","year":"2018","journal-title":"Liver Int."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.cgh.2018.11.030","article-title":"Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease","volume":"17","author":"Hagstrom","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2013.06.057","article-title":"Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"145","author":"Angulo","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/14397595.2018.1558760","article-title":"Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study","volume":"30","author":"Kim","year":"2020","journal-title":"Mod. Rheumatol."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Park, H.J., Park, J.Y., Jung, S.M., Song, J.J., Park, Y.B., and Lee, S.W. (2019). Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis. BMC Gastroenterol., 19.","DOI":"10.1186\/s12876-019-1007-z"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/COPD.S242863","article-title":"Hepatic Fibrosis Assessed Using Fibrosis-4 Index Is Predictive of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease","volume":"15","author":"Yong","year":"2020","journal-title":"Int. J. Chron. Obs. Pulmon. Dis."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1440-1681.12260","article-title":"Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD","volume":"41","author":"Xun","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Sebastiani, G., Alshaalan, R., Wong, P., Rubino, M., Salman, A., Metrakos, P., Deschenes, M., and Ghali, P. (2015). Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128774"},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Karajamaki, A.J., Patsi, O.P., Savolainen, M., Kesaniemi, Y.A., Huikuri, H., and Ukkola, O. (2015). Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142937"},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Mantovani, A., Pernigo, M., Bergamini, C., Bonapace, S., Lipari, P., Pichiri, I., Bertolini, L., Valbusa, F., Barbieri, E., and Zoppini, G. (2015). Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135329"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.03.027","article-title":"Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction","volume":"272","author":"Chung","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Saito, Y., Okumura, Y., Nagashima, K., Fukamachi, D., Yokoyama, K., Matsumoto, N., Tachibana, E., Kuronuma, K., Oiwa, K., and Matsumoto, M. (2020). Impact of the Fibrosis-4 Index on Risk Stratification of Cardiovascular Events and Mortality in Patients with Atrial Fibrillation: Findings from a Japanese Multicenter Registry. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020584"},{"key":"ref_270","unstructured":"Giangregorio, F., Mosconi, E., Debellis, M.G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., Kalaudi, O., Mustafazade, G., and Mar\u00edn-Baselga, R. (2024). Ultrasound splanchnic vascularization alterations in heart failure patients: A narrative review of the literature. J. Clin. Med., submitted."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., and Tiribelli, C. (2006). The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol., 6.","DOI":"10.1186\/1471-230X-6-33"},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Carli, F., Sabatini, S., Gaggini, M., Sironi, A.M., Bedogni, G., and Gastaldelli, A. (2023). Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914651"},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Heerkens, L., van Kleef, L.A., de Knegt, R.J., Voortman, T., and Geleijnse, J.M. (2023). Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0287467"},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Niu, Y., Wang, G., Feng, X., Niu, H., and Shi, W. (2023). Significance of fatty liver index to detect prevalent ischemic heart disease: Evidence from national health and nutrition examination survey 1999\u20132016. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1171754"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12933-024-02171-9","article-title":"Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: An 11-year observational study","volume":"23","author":"Garofolo","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13105-023-00991-z","article-title":"Fatty liver index (FLI): More than a marker of hepatic steatosis","volume":"80","author":"Kaneva","year":"2024","journal-title":"J. Physiol. Biochem."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_281","first-page":"9026","article-title":"Role of liver biopsy in nonalcoholic fatty liver disease","volume":"20","author":"Nalbantoglu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1007\/s00330-019-06072-4","article-title":"Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: A meta-analysis","volume":"29","author":"Gu","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.cgh.2020.08.061","article-title":"Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis","volume":"19","author":"Stine","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.cgh.2020.09.044","article-title":"Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD","volume":"19","author":"Gidener","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"e2329437","DOI":"10.2214\/AJR.23.29437","article-title":"MR Elastography: Practical Questions, From the AJR Special Series on Imaging of Fibrosis","volume":"222","author":"Yin","year":"2024","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/jum.15850","article-title":"Screening Protocol and Prevalence of Venous Thromboembolic Disease in Hospitalized Patients With COVID-19","volume":"41","year":"2022","journal-title":"J. Ultrasound Med."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ultrasmedbio.2024.03.014","article-title":"WFUMB Guidelines\/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification","volume":"50","author":"Ferraioli","year":"2024","journal-title":"Ultrasound Med. Biol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14366\/usg.21076","article-title":"Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis: A systematic review and meta-analysis of prospective studies","volume":"41","author":"Jang","year":"2022","journal-title":"Ultrasonography"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"W168","DOI":"10.2214\/AJR.16.16726","article-title":"A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease","volume":"208","author":"Paige","year":"2017","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/jum.15364","article-title":"Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom","volume":"39","author":"Labyed","year":"2020","journal-title":"J. Ultrasound Med."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2214\/AJR.22.27878","article-title":"Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard","volume":"219","author":"Dillman","year":"2022","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s11547-023-01693-8","article-title":"Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content","volume":"128","author":"Spoto","year":"2023","journal-title":"Radiol. Med."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1007\/s00247-023-05752-0","article-title":"Real-time ultrasound-derived fat fraction in pediatric population: Feasibility validation with MR-PDFF","volume":"53","author":"Zalcman","year":"2023","journal-title":"Pediatr. Radiol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"446","DOI":"10.14366\/usg.23014","article-title":"Toward acquisition protocol standardization for estimating liver fat content using ultrasound attenuation coefficient imaging","volume":"42","author":"Ferraioli","year":"2023","journal-title":"Ultrasonography"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1007\/s00261-024-04413-6","article-title":"Ultrasound backscatter coefficient for fat quantification is affected by the measurement depth","volume":"49","author":"Ferraioli","year":"2024","journal-title":"Abdom. Radiol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"e2330775","DOI":"10.2214\/AJR.23.30775","article-title":"Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population","volume":"222","author":"Kubale","year":"2024","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00261-023-04078-7","article-title":"A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD","volume":"49","author":"Zhu","year":"2024","journal-title":"Abdom. Radiol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1088\/0031-9155\/60\/11\/4497","article-title":"Full correction for spatially distributed speed-of-sound in echo ultrasound based on measuring aberration delays via transmit beam steering","volume":"60","author":"Jaeger","year":"2015","journal-title":"Phys. Med. Biol."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ultrasmedbio.2021.12.009","article-title":"A Preliminary Study of Liver Fat Quantification Using Reported Ultrasound Speed of Sound and Attenuation Parameters","volume":"48","author":"Ormachea","year":"2022","journal-title":"Ultrasound Med. Biol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.ultrasmedbio.2023.06.021","article-title":"Ultrasonic Sound Speed Estimation for Liver Fat Quantification: A Review by the AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative","volume":"49","author":"Wang","year":"2023","journal-title":"Ultrasound Med. Biol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5880\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:09:07Z","timestamp":1760112547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":300,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["jcm13195880"],"URL":"https:\/\/doi.org\/10.3390\/jcm13195880","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]}}}